Rithm Capital (RITM) stock slips below $11 as rate bets shift ahead of U.S. jobs data

Rithm Capital (RITM) stock slips below $11 as rate bets shift ahead of U.S. jobs data

New York, January 6, 2026, 10:53 EST — Regular session

  • Rithm Capital shares down about 1.5% in morning trading after Monday’s gain
  • Mortgage REITs often track Treasury yields and shifting Federal Reserve rate expectations
  • Next catalysts include Friday’s U.S. jobs report and Rithm’s expected early-February results

Rithm Capital Corp shares were down about 1.5% at $10.99 in morning trading on Tuesday, drifting back below the $11 mark a day after a sharp gain. The stock is still roughly 14% below its 52-week high of $12.74. StockAnalysis

The move matters because Rithm sits in the mortgage REIT corner of the market, where valuations can swing quickly with interest-rate expectations. Mortgage REITs use borrowing to buy mortgage-related assets, so changes in bond yields can alter funding costs and book value — the value of assets minus liabilities per share.

Income investors also focus on the payout. Rithm declared a quarterly common dividend of $0.25 a share, payable on Jan. 30, according to a company’s statement. Rithm Capital

Fed messaging has kept rate expectations on edge. Minneapolis Federal Reserve President Neel Kashkari said there was a risk the jobless rate could “pop” higher, and that the next policy move would depend on incoming data. Reuters

On Monday, the Institute for Supply Management said its manufacturing PMI — a survey index where readings below 50 signal contraction — fell to 47.9 in December, the lowest since October 2024. Wells Fargo economist Shannon Grein said the bank would “remain cautious” on the recovery, reinforcing investors’ focus on whether growth cools fast enough to pull rates down. Reuters

The benchmark U.S. 10-year Treasury yield was last around 4.18%, edging higher on the day as traders waited for more labor-market data. Shares of mortgage REIT peers were mixed, with Annaly Capital up about 0.5% while AGNC Investment and Starwood Property Trust slipped about 0.4% and 0.8%, respectively. Investing

Rithm gained 1.55% on Monday to close at $11.15, and trading volume topped its recent average, data showed. The stock outperformed some mortgage REIT peers in the prior session even as investors stayed sensitive to moves in rates and risk appetite. MarketWatch

The next company catalyst is earnings. Nasdaq lists Rithm’s next report as estimated for Feb. 5, with investors likely to watch dividend coverage, book value and any update on financing costs and mortgage spreads. Nasdaq

But the setup cuts both ways. If long-term yields push higher or credit spreads widen, mortgage asset values can fall and funding costs can rise, pressuring earnings and the income case for the shares.

Stock Market Today

  • Lilly to buy Ventyx Biosciences for $1.2 billion as obesity-pill bets sharpen
    January 7, 2026, 5:16 PM EST. Eli Lilly shares rose after it agreed to buy Ventyx Biosciences for $1.2 billion, expanding beyond diabetes and weight-loss drugs. Lilly closed up 4.1% at $1,108.09, after touching $1,117.37, valuing the company near $1 trillion. The cash offer of $14 a share is a 62% premium to Ventyx's 30-day VWAP (volume-weighted average price); Lilly expects closing in H1 2026, pending votes and regulators; about 10% of Ventyx shares have signed support. Lilly's research chief Daniel Skovronsky cited inflammation as a disease driver; Ventyx CEO Raju Mohan called the tie a strategic fit. The broader market was mixed: S&P 500 down, Dow lower, Nasdaq up ahead of payrolls data. Nimbus Therapeutics struck an AI-enabled obesity collaboration with Lilly; Lilly also eyes Aktis Oncology's IPO.
BigBear.ai stock rises 4% as BBAI debt redemption deadline nears
Previous Story

BigBear.ai stock rises 4% as BBAI debt redemption deadline nears

Exxon Mobil (XOM) stock slips after Venezuela-fueled rally as investors weigh oil supply risks
Next Story

Exxon Mobil (XOM) stock slips after Venezuela-fueled rally as investors weigh oil supply risks

Go toTop